secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000950170-25-085144
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spruce Biosciences wins Nasdaq appeal; must regain bid price compliance by Aug 5
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice April 22, 2025; stock moved to OTC Pink on April 29, 2025.
- On June 9, 2025, Nasdaq Hearings Panel accepted appeal; stock may resume on Nasdaq Capital Market if compliance met by August 5, 2025.
- Panel retains jurisdiction until October 20, 2025; any future non-compliance must be reported to the panel.
- Company seeks stockholder approval for reverse stock split (1:50 to 1:100) at July 22, 2025 annual meeting to cure bid price deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/0000950170-25-085144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/sprb-20250609.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-085144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer